SAIDs are a growing number of rare conditions (monogenic or multifactorial), secondary to disregulation of mechanisms controlling innate immune responses and characterized by sterile inflammation.For monogenic SAID, personalised medicine is already a consolidated reality; however new evidence suggests that even undefined SAID could benefit from this approach.The PerSAIDs Project aims to:-link together the larger SAID …
Multidisciplinary research project on personalised medicine –Development of clinical support tools for personalised medicine implementationin SAIDs (Systemic Auto-Inflammatory Diseases)
ISSAID 2023, 15-18 May, Toronto, CanadaPosterPredicting the Probability of FMF for Patients with Autoinflammatory Diseases by Using Machine Learning: First Insights from the PerSAIDs ProjectAyoub Abid, Fuat Akal, Ezgi Deniz Batu, Silvia Federici, Camilla Speziani, Francesca Bovis, Roberta Caorsi, Seher Sener, Nicola Ruperto, Isabella Ceccherini, Marco Gattorno, Seza Ozen
During the first 18 months there was a fruitful and active synergy between the partners to ensure the smooth development of all aspects of the project, with clinical activities, infrastructure configuration and analysis having to take place in parallel.In particular, the recruitment of samples and retrospective data saw a solid collaboration between the clinical centers, …
The official kick-off meeting of PerSAIDs “Personalised medicine per SAIDs” project was held online on 21 June 2022. The coordinator presented the overall project, followed by presentations by the 6 partners to introduce their organizations and the next steps. PerSAIDs is funded by the European ERAPerMED programme with 1,089,088 euros for 36 months, from May …
